Predict your next investment

Neuron Guard company logo
HEALTHCARE | Medical Devices & Equipment

See what CB Insights has to offer


Seed VC | Alive

Total Raised


Last Raised

$720K | 6 yrs ago

About Neuron Guard

Neuron Guard, founded in 2013, is developing a medical device for emergency brain protection to treat patients in case of Acute Brain Damage (ABD), directly at the site of the event. The solution is comprised of a refrigerating collar and a collar control unit, which can achieves and maintains the right level of therapeutic hypothermia of the head district.

Neuron Guard Headquarter Location

Via Castelvetro,15

Modena, 41124,


+39 0535 640264

Latest Neuron Guard News

Italy’s angels&incubators, fintech, crowdfunding and venture capital weekly roundup. News from Genenta Science, Delimobil, Viceversa, Neuron Guard, Biotechware and more

Nov 10, 2021

Italian-American Genenta Science will soon list on Nasdaq, sources said to BeBeez (See here a previous post by BeBeez). Genenta Science is developing cancer therapies based on stem cells and raised 30 million euros since ceo Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner founded it in 2014. Delimobil Holding, a Russian car sharing firm that owns the brands Delimobil, Anytime and Anytime.Prime, withdrew its listing plans on NYSE (see […]

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Neuron Guard

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neuron Guard is included in 1 Expert Collection, including Medical Devices.


Medical Devices

7,888 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.